Business Description
Personalis is a US-based genomics company that develops advanced cancer testing products and services for patients, healthcare providers, and life sciences organizations worldwide. Its core offerings include blood-based tests that detect traces of cancer remaining after treatment, monitor how well a therapy is working, and flag signs of recurrence, as well as tissue-based tests that give a detailed picture of a tumor to guide treatment decisions. The company also supports pharmaceutical and diagnostic firms with genomic sequencing for research, drug development, and clinical trials, and has a partnership with Tempus AI focused on colorectal cancer patients. Founded in 2011 and headquartered in Fremont, California, Personalis serves a broad range of customers from individual patients and physicians to universities, government agencies, and major drug makers.
